Structural Genomics Consortium, University of Oxford, Oxford, The United Kingdom.
PLoS One. 2013;8(3):e57644. doi: 10.1371/journal.pone.0057644. Epub 2013 Mar 7.
Soluble guanylate cyclase (sGC) catalyses the synthesis of cyclic GMP in response to nitric oxide. The enzyme is a heterodimer of homologous α and β subunits, each of which is composed of multiple domains. We present here crystal structures of a heterodimer of the catalytic domains of the α and β subunits, as well as an inactive homodimer of β subunits. This first structure of a metazoan, heteromeric cyclase provides several observations. First, the structures resemble known structures of adenylate cyclases and other guanylate cyclases in overall fold and in the arrangement of conserved active-site residues, which are contributed by both subunits at the interface. Second, the subunit interaction surface is promiscuous, allowing both homodimeric and heteromeric association; the preference of the full-length enzyme for heterodimer formation must derive from the combined contribution of other interaction interfaces. Third, the heterodimeric structure is in an inactive conformation, but can be superposed onto an active conformation of adenylate cyclase by a structural transition involving a 26° rigid-body rotation of the α subunit. In the modelled active conformation, most active site residues in the subunit interface are precisely aligned with those of adenylate cyclase. Finally, the modelled active conformation also reveals a cavity related to the active site by pseudo-symmetry. The pseudosymmetric site lacks key active site residues, but may bind allosteric regulators in a manner analogous to the binding of forskolin to adenylate cyclase. This indicates the possibility of developing a new class of small-molecule modulators of guanylate cyclase activity targeting the catalytic domain.
可溶性鸟苷酸环化酶(sGC)可催化一氧化氮反应生成环鸟苷酸。该酶是由同源的α和β亚基组成的异源二聚体,每个亚基由多个结构域组成。我们在此展示了α和β亚基催化结构域的异源二聚体以及β亚基的无活性同源二聚体的晶体结构。这种第一个后生动物的异源三聚体环化酶结构提供了几个观察结果。首先,这些结构在整体折叠和保守活性位点残基的排列上与已知的腺苷酸环化酶和其他鸟苷酸环化酶结构相似,这些残基由界面上的两个亚基共同贡献。其次,亚基相互作用表面是混杂的,允许形成同二聚体和异二聚体;全长酶对异二聚体形成的偏好必须来自于其他相互作用界面的综合贡献。第三,异源二聚体结构处于无活性构象,但通过涉及α亚基 26°刚性体旋转的结构转变,可以与腺苷酸环化酶的活性构象叠加。在模拟的活性构象中,亚基界面上的大多数活性位点残基都与腺苷酸环化酶的残基精确对齐。最后,模拟的活性构象还揭示了一个通过伪对称与活性位点相关的空腔。伪对称位点缺乏关键的活性位点残基,但可能以类似于佛司可林与腺苷酸环化酶结合的方式结合别构调节剂。这表明有可能开发出一类针对催化结构域的新型小分子鸟苷酸环化酶活性调节剂。